Celox Labs announces formation of Protide Pharmaceuticals.
The company also says ViaStem may improve the transfusion of these critical cells which are responsible for producing white blood cells, red blood cells and platelets. Protide will continue to collaborate with the University of Minnesota to complete the preclinical studies of ViaStem.
Contact: David Tess - (651) 730-1500
|Printer friendly Cite/link Email Feedback|
|Comment:||Celox Labs announces formation of Protide Pharmaceuticals.|
|Date:||Mar 10, 1999|
|Previous Article:||CryoLife receives CE mark for international distribution of new bioglue delivery system.|
|Next Article:||Aastrom Biosciences receives CE mark for cord blood kit.|
|Court issues approval of Nanophase's settlement.|
|High-speed CELOX: slick, eye-catching endload cartoner from Kliklok-Woodman.|
|McVitie's Jaffa cakes.|